Abstract |
In this multicentric random double-blind study versus placebo, the therapeutic activity of timed-release dihydroergotamine preparation 10 mg/per os/day has been tested in 90 patients affected by common migraine. The drug presented a prophylactic effect on recurrent headache, mainly on night and awakening migraine. A low incidence of side-effects with no weight changes or other effects on physiologic events was registered.
|
Authors | N Martucci, V Manna, P Mattesi, G Troiani, G C Manzoni, M Lanfranchi, G Bono, G Micieli |
Journal | Cephalalgia : an international journal of headache
(Cephalalgia)
Vol. 3 Suppl 1
Pg. 151-5
(Aug 1983)
ISSN: 0333-1024 [Print] England |
PMID | 6352046
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Delayed-Action Preparations
- Dihydroergotamine
|
Topics |
- Adult
- Clinical Trials as Topic
- Delayed-Action Preparations
- Dihydroergotamine
(therapeutic use)
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Migraine Disorders
(drug therapy, prevention & control)
- Random Allocation
- Recurrence
|